Attoui, H.; Mohd Jaafar, F.; Monsion, B.; Klonjkowski, B.; Reid, E.; Fay, P.C.; Saunders, K.; Lomonossoff, G.; Haig, D.; Mertens, P.P.C.
Increased Clinical Signs and Mortality in IFNAR(−/−) Mice Immunised with the Bluetongue Virus Outer-Capsid Proteins VP2 or VP5, after Challenge with an Attenuated Heterologous Serotype. Pathogens 2023, 12, 602.
https://doi.org/10.3390/pathogens12040602
AMA Style
Attoui H, Mohd Jaafar F, Monsion B, Klonjkowski B, Reid E, Fay PC, Saunders K, Lomonossoff G, Haig D, Mertens PPC.
Increased Clinical Signs and Mortality in IFNAR(−/−) Mice Immunised with the Bluetongue Virus Outer-Capsid Proteins VP2 or VP5, after Challenge with an Attenuated Heterologous Serotype. Pathogens. 2023; 12(4):602.
https://doi.org/10.3390/pathogens12040602
Chicago/Turabian Style
Attoui, Houssam, Fauziah Mohd Jaafar, Baptiste Monsion, Bernard Klonjkowski, Elizabeth Reid, Petra C. Fay, Keith Saunders, George Lomonossoff, David Haig, and Peter P. C. Mertens.
2023. "Increased Clinical Signs and Mortality in IFNAR(−/−) Mice Immunised with the Bluetongue Virus Outer-Capsid Proteins VP2 or VP5, after Challenge with an Attenuated Heterologous Serotype" Pathogens 12, no. 4: 602.
https://doi.org/10.3390/pathogens12040602
APA Style
Attoui, H., Mohd Jaafar, F., Monsion, B., Klonjkowski, B., Reid, E., Fay, P. C., Saunders, K., Lomonossoff, G., Haig, D., & Mertens, P. P. C.
(2023). Increased Clinical Signs and Mortality in IFNAR(−/−) Mice Immunised with the Bluetongue Virus Outer-Capsid Proteins VP2 or VP5, after Challenge with an Attenuated Heterologous Serotype. Pathogens, 12(4), 602.
https://doi.org/10.3390/pathogens12040602
